课题基金 / 基金详情

Mutation Based Classification of Endometrial Carcinomas for Improved Targeted Therapeutics

Mutation Based Classification of Endometrial Carcinomas for Improved Targeted Therapeutics
基于突变的子宫内膜癌分类以改进靶向治疗
批准号：
226953
负责人：
McConechy Melissa K
金额：
$1.27万
依托单位：
BC Cancer, part of PHSA (Vancouver)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-02-01 至 2012-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=226953&lang=en
关键词：
Endometrial Carcinoma Molecular Classification Next Generation Sequencing Oncogenes Pathology Somatic Mutations Tumour Suppressors

项目摘要

项目成果

McConechy Melissa K的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Uterine cancer, also known as endometrial cancer, is the most common gynaecological cancer for Canadian women. In 2010, uterine cancer is ranked as the fourth most common type of women cancer, with approximately 4500 new cases being diagnosed yearly. Over
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization of tumour-specific epigenetic changes in high-grade pediatric brain cancers and giant cell tumour of the bone
Characterization of tumour-specific epigenetic changes in giant cell tumour of the bone and high-grade pediatric brain cancers
Mutational and Functional Analysis of PPP2R1A in High Risk Endometrial Carcinomas
  • 批准号：
    283913
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2012
  • 负责人：
    McConechy Melissa K
  • 依托单位：
    BC Cancer, part of PHSA (Vancouver)
海外基金